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Abstract 
AIM: Many of the eye care practitioners (ECPs) in Saudi Arabia practice in optical stores. These stores are wide 
spread, easily assessable and seldom need appointments. The expanding role of the ECP as a primary health care 
provider (PHCP) and the increasing global prevalence of hypertension, highlight the need for an integrated 
approach towards management of hypertension. This pilot study sort to investigate the number of hypertensive 
patients the ECP is able to identify by routinely taking blood pressure (BP) measurements and the patients’ 
opinion regarding in-office BP measurement. 
METHODS: Automated BP measurements were twice obtained in five selected optometry practices using a 
validated BP monitor (Omron M6) to access the number of patients with high BP (HBP) visiting the eye clinic 
routinely. Prior to data collection, practitioners underwent a two-day training workshop by a cardiologist on 
hypertension and obtaining accurate BP readings. A protocol for BP measurement was distributed and kept in all 
participating clinics. The general attitude towards cardiovascular health of 480 patients aged 37.2 (12.4) years and 
their opinion towards in-office BP measurement was assessed using a self-administered questionnaire.  
RESULTS: There is an increased awareness of hypertension in Saudi Arabia, but with a general poor attitude by 
patients towards their cardiovascular health. A response rate of 83.6% was obtained from the survey and 
participants were very positive (54%) in their opinion regarding the monitoring of BP in eye clinics. Many of the 
patients (69.8%) appreciated the routine measurement of BP in optometry practices. They stated that it was not 
time consuming (31.5%) and will save time they would have spent visiting a hospital for such routine checks 
(64%). Patients (38.5%) also do not think their BP status is related to their ability to see well. Ninety-three of the 
443 patients (21.0%) tested for BP in this study had HBP. Of these 93 subjects, 67.7% were unaware of their HBP 
status. Thirty of the 105 subjects (28.6%) who had previously been diagnosed had HBP at the time of this study 
and only 22 (73.3%) were on medication. Also, only 25% of the previously aware hypertensive patients owned a 
BP monitor. 
CONCLUSION: Taking BP measurement in optometry practice is able to identify one hypertensive patient for 
every 8 adults tested with HBP who were unaware and patients appreciate the routine measurement of BP by the 
Optometrists. These findings re-iterate the potential role of eye care practitioners towards early 
detection/monitoring of the hypertensive patient. 
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INTRODUCTION 
The diagnosis and management of chronic diseases such as diabetes and hypertension require a multidisciplinary 
approach to provide optimal patient care[1]. Such a team approach, when utilized in the care of patients with 
chronic conditions is associated with improved outcomes[2,3] and greatly reduces the risk of 
complications[4].Optometry is a primary care profession among other health care providers (HCPs), patients and 
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the public[5,6], and the optometrists in most developed countries have long been responsible for detecting not only 
ocular diseases but systemic diseases with ocular manifestations[7-11] such as vascular hypertension.  
Systemic hypertension does not only seriously affect vision and the visual system, it is also a threat to life[9] as it is 
the single most common cause of worldwide morbidity and mortality[12-14] and often has very few warning signs. 
Systolic BP and diastolic BP have been shown to be strong predictors of death due to cardiovascular disease 
(CVD)[15-19] In the USA and northern Europe, it accounted for approximately 70 deaths per 10 000 person-years as 
compared to approximately 20 deaths per 10,000 person-years in Japan and Mediterranean southern Europe[16]. 
Low- and middle-income countries are disproportionally affected[20] and currently, hypertension deaths in Saudi 
Arabia accounts for more than 12.24% of total deaths (the 4th largest in the world)[21]. 
Diagnosis and treatment of systemic hypertension is not always clear cut as the BP level at which management is 
instigated may differ between patients and the individual affected may remain asymptomatic for many years[22]. 
To aid management, the Joint National Committee on Prevention, Detection, Evaluation and Treatment of HBP17 
have classified BP into groups, according to measures of systolic and diastolic BP. Despite these classifications 
and the availability of effective treatment modalities, control rates are not satisfactory globally[23,24]. It has been 
shown that many who know they are hypertensive are not on treatment, and many of those on medication have 
blood pressures that not fully controlled[25,26]. Therefore, to ensure early detection and treatment of hypertension, 
some authors[25-27] have suggested the need to develop a HBP screening and education program, and to design a 
comprehensive program aimed at improving the knowledge, attitude, and behavior of patients and all health care 
practitioners[28]  
The ocular manifestations of systemic hypertension involve the retinal, choroidal and optic nerve head 
vasculature[29-32]. Retinopathy associated with HBP is the second most common retinal vascular disease after 
diabetic retinopathy[12], while the risk of developing glaucoma (the second leading cause of irreversible blindness 
worldwide) is thought to increase in the presence of has both systemic hypertension and systemic hypotension 
[33,34]. Detection of these ocular changes require ophthalmoscopic examination but, because cardiovascular 
compromise and other organ system damage may occur prior to the practitioner picking up these changes, an 
evaluation of hypertension is incomplete without assessing the patients systemic BP[22]. 
The need for routine BP measurement in optometry clinics is long been identified[7-10, 22, 35, 36] but it appears to 
have been generally ignored by optometrists despite the rising prevalence of hypertension. Whereas the clinical 
use of sphygmomanometer in the eye examination has been part of the optometry syllabus in developed 
countries[9,10,35,37] it is not currently the case in developing countries such as Saudi Arabia where optometrists 
(many of who practice in optical stores) are trained to detect ocular and systemic disease through examination of 
the eye, rather than general BP measurement techniques. But, with the decline in use of mercury 
sphygmomanometer38 and the widespread use of automated BP monitors, many optometrists in this region now 
have access to a BP monitor[39]. In previous surveys [10,39], optometrists have stated that patients will appreciate in-
office measurement of BP, if it eventually becomes a routine practice and that such practices will be effective in 
identification of patients with HBP. Previous studies assessing the role of optometrists in detection of patients 
with HBP have either being conducted many decades ago (when the prevalence of hypertension was not as high as 
it is today)[7-9] or have been conducted in selected high risk patients [36] or have based their findings only on 
surveys with no actual measurement of BP [8,39] and/or, have only reported their findings based on the opinion of 
the optometrists alone disregarding that of the patients visiting these optometry practices where BP measurement 
is uncommon.[22,39] 
Considering the fact that new automated oscillation sphygmomanometer increase the objectivity and repeatability 
of (and reduce the amount of chair time and examiner skill necessary to take) BP measurements[40,41] and because 
BP measurements combined with ophthalmoscopic signs (such as narrowing of arterioles etc) are a much stronger 
diagnostic sign of hypertensive retinopathy than ophthalmoscopy signs alone[22], it would be necessary to actually 
evaluate the impact of incorporating routine BP measurement into optometry practice on detection of patients with 
hypertension in this current era. It is also important to assess the opinion of the patients towards making BP 
measurement an integral part of routine optometry examination.  Nevertheless, it would make the best interests of 
both Optometric practitioners and the general public if Optometrists incorporate BP measurement into their 
practices, using clinically validated monitors. Daubs[42] had earlier projected that 1/14 undiagnosed hypertensive 
patients would be discovered if optometrists took up BP assessment routinely.  
Therefore, the purpose of this study was two-fold: 1) the actual measurement of the BP of patients, in optometry 
practice to assess their BP status, determine the percentage of patients with HBP who may have been aware but 
not treated, or on treatment but not properly controlled, or unaware and thus require referral, and refer those 
patients to General Practitioners (GP) and/or Internists; 2) to determine the level of knowledge of patients at-risk 
of, or diagnosed with, hypertensive disease of their BP status and CV health; and 3) to gauge the patients’ opinion 
concerning in-office BP measurement by the Optometrist. 
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SUBJECTS AND METHODS 
Subjects  Approval for this study was obtained from the Research Ethics Committee of the College of Applied 
Medical Sciences, King Saud University and the study was performed in accordance with the Declaration of 
Helsinki of 1975, as revised in 2000. Informed consent was obtained from all participating patients, prior to 
enrollment, after the study protocol (and their rights as participating subjects) had been explained to them.  
Subjects for the questionnaire study were recruited from adult patients visiting the optometry practices and a 
subset of the adult subjects who also agreed to participate in the BP study also had their blood pressure assessed. 
Patients who were on systemic medications other than anti-hypertensive medications were excluded from 
participation in the actual BP measurement section. Participation of optometry practices was by invitation which 
was sent out by regular mail to registered optometry practices (popularly known as optical stores) in Riyadh. The 
optical stores selected were those licensed to conduct eye examinations as many others are allowed to sell optical 
aids but no eye examinations. The practices that responded were requested to nominate an optometrist to 
participate in the training session. Thus, for each practice, only one location and one optometrist was selected and 
trained respectively, to participate. The study was conducted between August and December 2013. 
Questionnaire study  The first part of this study adopted a similar protocol as was used by Osuagwu et al[39] and 
Hurcomb and Wolffsohn[10] with a few modifications to specifically address the purpose of this study (Table 1): 
To refine and validate the survey, we conducted a two-stage empirical validation study consisting of a pretest with 
a panel of domain experts followed by a field test among all eligible prescribers at our institution and by ten 
randomly selected patients visiting different optometry practices. The self-administered questionnaire was drafted 
simultaneously in both English and Arabic languages. The final questionnaire shown in Table 1 was sent out to 
patients visiting the participating optometry practices. A technician was responsible for distribution and collection 
of all completed surveys. The questionnaires were included in the analysis if they were completed by adult 
patients visiting the optometry practices and excluded if they had participated in the initial validation of this 
questionnaire.  
BP study protocol  The second part of this study involved an in-office measurement of BP of patients in selected 
practices in Riyadh. The nominated optometrists were required to attend a two-day active training workshop by a 
Cardiologist (HM) on hypertension and the use, operation, and calibration of the automated oscillatory BP 
monitor, the Omron M6 Comfort (OMRON Healthcare Co., Ltd., Kyoto, Japan), used in this study.  During the 
training sessions, to ensure accuracy of BP readings, the optometrists had to measure arm sizes of practice 
subjects to get a gauge of patient's arm sizes in relation to body size. The clinicians were asked to measure the arm 
size of a patient, during the data collection, if they taught it might exceed 42cm or be less than 22cm. The Omron 
M6 uses a long comfort cuff size designed to fit arm circumference (22 - 42 cm) of most subjects. The Omron M6 
was selected for use in this study because it’s one of the automated validated devices[43] and for its comfort cuff. 
Seven Omron M6 BP monitors was distributed to the participating optometrists for the purpose of data collection.   
The protocol for measuring BP followed that outlined in Parati et al[44]. First, the optometrist was required to 
inquire if patients: 1) have been diagnosed with hemi- or para-plegia? If hemiplegia, which side? 2) had exercised 
or taken tea or any form of coffee in the last one hour. Following this, in the measurement of BP, the protocol 
detailed in table 2 had to be followed to the letter. The rooms in which the BP measurements were to be taken 
were inspected by one of the members of the research team and the BP protocol was required to be pasted up on 
the wall as a reminder to the participating optometrist. 
BP measurement protocol BP measurement was obtained in the optometry practices based on the protocol 
outlined below which was pasted on the walls of the participating optometry offices and all optometrists were 
required to follow the instructions to the letter.  
1. The subject must sit upright in the measurement position (with his/her feet flat on the ground) in a quiet room 
for five minutes prior to the measurement, with no talking, movement or leg crossing.44 
2. Always use the left arm for BP measurements, except if the subject has a history of paralysis affecting that arm. 
3. Subject's arm must be in horizontal position for measurement and it must be at approximately the same level as 
the heart. 
4. Based on the two earlier training sessions we had, if you are suspicious that the circumference of the subject's 
arm is either greater than 42cm or smaller than 22cm, measure the circumference of the arm with your soft 
(tailor's) tape and record the arm circumference with the BP reading. 
5. Wrap the cuff around the subject's upper arm, just above the highest visible depression of the antecubital space, 
with the inflation tube  placed inferiorly, approximately in line with the middle finger of the open, upward-
facing palm. 
6. Take 2 sets of measurements 2 - 3 minutes apart. Practitioners were advised to always record the arm used for 
BP measurement in all cases of hemi- or para- plegia and to identify patients who have consumed tea, coffee and 
caffeinated drinks less than 1 hour before BP measurement by marking an ‘asterix’ beside their names. 
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All these were done to limit the number of false positive referrals. Subjects were seated upright in a chair in the 
measurement position (with his/her feet flat on the ground) in a quiet room for five minutes prior to the 
measurement, with no talking, movement or leg crossing[44]. The left arm was bared and always used for BP 
measurements, except if the subject had a history of paralysis affecting that arm, then the right arm was used and 
recorded. The subject's arm was supported in a horizontal position at approximately the same level as the heart 
and the cuff was wrapped around the subject's upper arm, just above the highest visible depression of the 
antecubital space, with the inflation tube placed inferiorly, approximately in line with the middle finger of the 
open, upward-facing palm. Two readings separated by at least 2 minutes were obtained and averages recorded. In 
cases where the average systolic BP reading was ≥ 140 mm Hg or the diastolic BP ≥ 90 mm Hg, the patient was 
considered to have HBP [45, 46] and was issued a referral letter to their respective GPs with: the BP reading; the 
time of measurement; the device and cuff size used; and the arm that was measured, all included in the referral 
report.  
Based on the two earlier training sessions conducted, the optometrists were also required to measure the 
circumference of the arm with a soft (tailor's) tape that was supplied to them and record the arm circumference 
with the BP reading. This procedure was carried out only if the participating optometrist was suspicious that the 
circumference of the subject's arm was either greater than 42cm or smaller than 22cm. In order to limit examiner 
bias, the optometrist taking the BP measurement was blinded to the survey response of the patient in all cases 
where such patients took part in both studies. BP measured from patients who had taken coffee, tea or caffeinated 
beverages and exercise or carried out any strenuous activity less than an hour prior to BP measurement, were 
excluded from the analysis. 
All BP measurements were obtained between 16.00 and 22.00 hrs, since a marked surge in BP has been shown to 
occur in the morning, decreasing through the day to a trough level in the evening [47]. All data were transferred at 
the end of each day to a central collection center by email and stored on a personal computer.  
Statistical Analysis  All responses obtained from the survey were self reported and the results were entered into a 
Microsoft Excel spreadsheet, overlaid to eliminate data errors and corrected. Analysis was performed using the 
SPSS statistical software version 16.0 (SPSS Inc., Chicago, USA). The scoring system was performed in a similar 
manner to that used in a previous study[39] for each numerical grade in the questionnaire. Results obtained from 
the actual BP measurements were analyzed using descriptive statistics and frequency distribution graphs were also 
drawn.   
RESULTS 
Of the eleven optometry practices in Riyadh that indicated their willingness to participate in this study only seven 
(63.6%) of the nominated optometrists attended the training sessions and were allowed to participate in the data 
collection of this study. 
Analysis of Survey Participants (n = 480) 
Demographics of participants Of the 574 eligible participants who visited the optometry practices during the 
study period, 480 (83.6%) agreed to participate in the survey. They include 411 males (87.8%), 64 females 
(13.7%) and 5 participants who did not specify their gender (1.1%). The average age (± SD) was 37.2 (± 12.4) 
years, with an age range between 19 and 90 years. The remaining 94 declined for time reasons. A hundred and 
eighty-nine of the participants were married (39.4%), 63 single (19.8%) and 223 unspecified status (46.5%). The 
demographic data and nature of employment of the participants have been represented in Figure 1A & B, 
respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Demography of all patients (n = 480) showing: A) Nature of Employment and B) Countries of origin  
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Opinions of patients concerning in-office measurement of BP by the Optometrist  Table 2 is the analysis of 
percentage responses of participants for each question asked. On the average, patients were positive in their 
disposition toward the use of BP monitors routinely in optometry practices, and felt BP measurement in optometry 
practice does not involve extra chair time but rather it saves time they would have spent in a hospital. Many also 
believed that their BP status is unrelated to their vision.  
Table 2. Patient Responses to questions on their opinion towards in-office blood pressure (BP) measurement 
Questions Asked 
Responses obtained from 480 patients 
Agree Disagree Neutral No response 
Appreciated by px 335 (69.8%) 14 (2.9%) 32 (6.7%) 99 (20.6%) 
Unrelated to vision 185 (38.5%) 103 (27.1%) 91 (19.0%) 101 (21.0%) 
Advances profession 275 (57.3%) 31 (6.5%) 71 (14.8%) 103 (21.5%) 
Eliminates Hospital time 307 (64.0%) 15 (3.1 %) 54 (11.3 %) 104 (21.7%) 
Only on Indication 154 (32.1%) 122 (25.4%) 92 (19.2%) 122 (23.3%) 
For GPs only 122 (25.4%) 126 (26.3%) 122 (25.4%) 110 (22.9%) 
For Optometrist as well 259 (54.0%) 28 (5.8%) 80 (16.7%) 113 (23.5%) 
Concurrent with change of Rxn 234 (48.8%) 50 (10.4%) 86 (17.9%) 110 (22.9%) 
Takes extra px chair time 115 (24.0%) 151 (31.5%) 97 (20.2%) 117 (24.4%) 
Should be performed routinely     
In Optometry Practice 206 (42.9%) 50 (10.4%) 115 (24.0%) 109 (22.7%) 
Raises anxiety 103 (21.5%) 200 (41.7%) 67 (14.0%) 110 (22.9%) 
GPs will frown at it 87 (18.1%) 140 (29.2%) 147 (30.6%) 106 (22.1%) 
*GP = general practitioner; Rxn = prescription; px = patient 
Analysis of responses to questions regarding patients' awareness of their health  Of the 438/480 (91.3%) 
participants who responded to this section of the interview, 114 (26.0%) stated they had been previously 
diagnosed with HBP. Of this previously diagnosed HBP participants, only 105/114 (24.4%) stated when they were 
diagnosed with 69/114 (60.5%) having been diagnosed in the last 2 years, 22/114 (19.3%) in the last 2 - 5yrs, 
11/114 (9.7%) in the last 5 - 10 years, 3/114 (2.6%) more than 10 years ago and the rest 9/114 (7.9%) did not 
respond.  
Two hundred and ninety-eight of the 438 participants (60%) who stated they had not been previously diagnosed 
with HBP. Among this group of participants, 13 (4.4%) had been previously diagnosed with low BP and thus 
were not included in this analysis. A breakdown of the elicited responses from only the participants who 
responded to this survey section shown in Table 2 reveal among other things that, of the 298 participants who 
stated they have not been diagnosed of HBP, two third (293/298; 98.3%) were not on any hypertensive 
medications, four (1.3%) were on medications while the remaining participant (0.3%), failed to respond.   
Regarding their last BP Check, 236/480 patients responded (61.7%), among whom: one patient (0.4%) had 
checked his BP 2 days ago; 93 patients (39.4%) between 1-3 months ago; 59 patients (25%) between 3-6 months; 
41 patients (17.4%) between 6 months - 1year ago; 41 patients (17.4%) between 1-2 years; and another one 
patient (0.4%) between 5-10 years ago. 
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Analysis of responses obtained regarding the related risk factors  Four hundred and twenty-one responses 
were obtained (421/480; 87.7%), and the breakdown was drawn in Figure 2. It shows that many participants 
reported a family history of hypertension (174/421; 38%). 
Figure 2. Percentage Distribution of risk factors reported by survey patients 
 
 
Regarding related symptoms, a hundred and forty-one of 480 participants (29.4%) responded and thus were 
analyzed (Figure 3). Blurred vision was the most reported symptom (64/141; 45.4%), nosebleed was the least 
(10/141; 7.1%) while some respondents also experienced a combination of two or three symptoms.  
Figure 3. Percentage Distribution of other related symptoms reported by survey patients 
 
Analysis Involving Only the Participants of BP Measurement Study (n = 433) 
Study population  For the second part of this study, of the 480 participants in the survey, 460 (95.8%) also 
agreed to have their BPs measured for the second part of the study. Of this subset of participants, BP 
measurements obtained from only 443 patients (96.3%) were analyzed. The patient sample included 384 men 
(86.7%) and 58 women (13.1%), with a mean age (SD) of 37.3 (12.5) years (range, 19 – 90 years). Of the other 17 
patients (3.7%), five (29.4%) declined to have their BP readings taken after having initially consented. The other 
12 (70.6%) had consumed caffeinated beverages or had carried out strenuous activity less than one hour prior to 
when the BP measurements were to have been made.  
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For the 443 participants, the mean (SD) value of the measured systolic and diastolic BP, respectively, were 123 
(17) mmHg (range, 84 – 192 mmHg) and 78 (11) mmHg (range, 47 – 114 mmHg).  
Analysis of survey responses of BP measurement participants (n = 443)  An analysis was performed by 
categorizing the participants into their self-reported BP status: Previously diagnosed HBP (n = 105); previous 
diagnosed as normal (n = 46); unknown BP status (n = 11); and unspecified BP status (n = 46).  The analysis of 
responses obtained only from this sub-group of patients (previously diagnosed HBP patients, previously 
diagnosed normal patients, and previously unsure patients) on their attitude towards their cardiovascular health, 
and the number of patients from each group who had HBP at the time of this study, have been shown in Figure 4. 
Figure 4. The number of newly diagnosed high blood pressure (HBP) patients and analysis of the patient attitude towards 
their cardiovascular health  
 
Figure 5 shows the responses of patients (previously diagnosed HBP patients, previously diagnosed normal 
patients, previously unsure patients and those who failed to specify their status) concerning the related risk factors 
sort for. Further analysis showed the following: 
Of the previously diagnosed HBP patients: When BP measurement was obtained in this group of patients, 30/105 
patients (28.6%) showed a HBP. Of these 30 patients, 73% (22/30) were on medications while 26.7% (8/30) were 
not, at the time of this study. Of those on medications, 45.5% (10/22) were taking more than one medication. 
Also, 45.5% (10/22) of those taking either one or two medications stated that they sometimes or always forgot to 
take their medications. Also, concerning the remaining patients who showed normal BP readings at the time of 
this study, 44% (33/75) were on medications and 15.2% (5/33) were on more than one medication. In general, 
about 45.5% (15/33) also stated they sometimes or always forgot to take their medications. 
Of the unsure BP status patients: On obtaining measurement of their BP, 4/17 patients (23.5%) showed HBP 
readings and none was on hypertensive medication at the time of study. 
Of the previously diagnosed normal BP Patients: On obtaining measurement of their BP, 51/275 patients (18.6%) 
showed HBP readings, and only one patient (1/51; 2.0%) was on medication at the time of study while 2 of the 
remaining 224 confirmed normal patients (0.9%) were also on antihypertensive medications. 
Of the Unspecified BP status patients: On obtaining measurement of their BP, 8/46 patients (17.4%) showed HBP 
readings and none of them was on hypertensive medication, as they all failed to respond to the questions on 
cardiovascular health.  
Overall, 93 of the 443 patients (21.0%) tested for BP in this study had HBP. At the time of this study 67.7% of 93 
patients (or 14.2% of 443 patients whose BPs were measured in this study) were unaware of their HBP status. All 
participants who revealed HBP measurements were referred to their respective physicians for confirmation and 
possible management with the readings obtained, the arm measured, the device used, the cuff size, and the time of 
measurement all recorded on their referral forms. 
Analysis of related risk factors for BP measurement participants only  Figure 5 also shows the result of the 
analysis concerning the related risk factors. From the figure, we can deduce that 347/443 patients (78.3%) whose 
BPs were obtained did not exercise at all, while 98/443 (22.1%) were either full time or part time smokers. 
Amongst the other risk factors commonly sort for in optometry clinics, a positive family history of hypertension 
was predominant (90/443; 20.3%). Notably, all the risk factors sought for were predominantly reported by 
participants who stated they had not been previously diagnosed of HBP (Figure 5). 
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Figure 5. Percentage Distribution of the risk factors reported by patients whose blood pressures (BPs) were measured.  
 
DISCUSSION 
With the expanding role of the eye care practitioners as primary health care providers our group this pilot study 
investigated how many hypertensive patients the eye care practitioner (ECP) is able to identify and thus refer if in-
office BP measurement is incorporated in optometry clinics. Measurement of BP is not currently part of the 
routine optometric examination in Saudi Arabia and in developed countries outside the United State[10, 22]. This is 
because many of the ECPs in Saudi Arabia practice in optical stores which mainly sale optical aids with some that 
are also licensed to conduct eye examinations. Thus, this study was necessary mainly due to the rising prevalence 
of hypertension in the region[19-21,25,27] and the suggestion from an earlier study that ECPs were willing to make 
BP measurement a routine practice and thus refer patients considered to be at-risk to their GPs for proper 
diagnosis and management thereof, but needed more training in order to effectively and confidently do so[39]. 
Private optometry practices were chosen because in comparison to hospitals in the region, they are spread far and 
wide, much easily accessible with less chair time, much more readily and frequently visited, and seldom the need 
for an appointment, they would serve as an ideal avenue to catch those unaware of their HBP status.  
Sample, Location and Demography for all participants  The response rate obtained in the survey study was 
higher than that of previous studies[8, 10, 22, 39, 35], and even much higher in the BP study because we wanted to get 
as many of questionnaire fillers to have their BP taken, so we distributed the questionnaires only in the 
participating clinics at the time of exam. The participating sample in the current study was skewed towards a 
preponderance of male subjects as more men than women were observed to be more willing to participate and 
answer the mildly intrusive questions about personal health issues. Saudi Arabia is a conservative, paternalistic 
country and as such the second explanation for the preponderance of male participants in this study is the more 
likely. The study also depicted the increasingly cosmopolitan nature of Riyadh, as it featured several different 
nationalities but with a majority of Saudis (62.7%) Figure 1B, most of who were employed in private and 
government institutions (Figure 1A). 
Opinions of Patients on In-office BP Measurement in Optometry Practices  The patients showed great 
support regarding the optometrists taking BP measurements during routine eye checks. This finding is consistent 
with a previous report[39]. Contrary to popular belief that BP measurement in optometry practices was time 
consuming; such a practice was viewed by the patients as not being time consuming and would advance the 
profession (Table 2). This is understandable considering the ease with which patients could get their BP assessed 
if such practice is adopted routinely in optometry practices. This situation is in contradistinction to that in 
hospitals where patients in need of such simple checks spend so much time and are often moved from one station 
to the other due to the size of these facilities, and the multiservice functionality of hospitals[6].  
Attitude of Patients on Their Vascular Health in Relation to Current BP Status  This study show that 
majority of the patients (94.1%) visiting optometry practices in Saudi Arabia are aware of their BP status with 
some having been previously diagnosed as having HBP and many previously diagnosed as not having HBP (i.e. 
their BPs were normal). On the other hand, a small number of participants (4.2%) had never been screened for 
hypertension and as such, were unaware of their BP status at the time of this study (Table 3). About one-half of 
the previously diagnosed HBP patients were not on any medication despite 60.5% of them having been diagnosed 
as recently as 2 years ago. Of the other half who was on medication, almost all were not compliant with their drug 
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administration instructions, as they either sometimes or always forgot to take their medications. In addition, many 
(32.5%) of those previously diagnosed HBP did not know the antihypertensive medications they were taking. 
Notably, many of the participants shied away from questions inquiring of their awareness towards the medications 
they were using and if they forgot to take them. These findings are consistent with previous studies showing that 
most adults were aware of their hypertension status[48], but that many hypertensive individuals do not care about 
regulating their BPs despite being diagnosed with HBP[27, 28, 49]. 
Table 3 Patient responses on their knowledge and attitude towards their vascular health 
Response on Vascular Health  Yes   No Not sure No Response 
Previous History of HBP (n =438) 114 (26%)  298 (68%) 18 (4.1%) 8 (1.8%) 
On medications (n = 438) 61 (13.9%)  293 (66.9%) 1 (0.2%) 83 (18.9%) 
Forgets to take medications (n = 114) 17 (14.9%)  38 (33.3%) 35 (30.7%) 24 (21.1%) 
Knows the medications(n = 114) 37 (32.5%)  57 (50%)    5 (4.4%) 15 (13.2%) 
On more than one medication (n=114) 15 (13.2%)  80 (70.2%)    4 (3.5%) 15 (13.2%) 
Owns a BP monitor (n = 438) 43 (9.8%) 328 (74.9%)     0 (0%) 67 (15.3%) 
Remembers last BP reading(n = 438) 98 (22.4%) 225 (59.4%)    40 (9.1%) 75 (17.1%) 
 
Another finding of this study was that, only about 12% of patients owned a BP monitor (Table 3) despite the large 
number of participants (39.8%) in the BP measurement study being within the age bracket (40 years and above) 
shown to exhibit a higher prevalence of hypertension in comparison to other age groups[48]. Interestingly, many of 
the previously diagnosed HBP patients did not have a BP monitor (Figure 4), neither did ninety-percent of the 
newly diagnosed HBP patients (as confirmed after BP measurement in this study). National Institute for Health 
and Care Excellence (NICE) guideline for hypertension management[45] empowers patients to become more 
involved in the monitoring and care of their hypertension by home BP monitoring (HBPM). Optometrists should 
therefore encouraged their patients (especially those with HBP) to own a BP monitor since monitoring their own 
BP is a more accurate predictor of long-term morbidity[50]and helps to improve health outcomes for the patients 
with hypertension[51].  
BP Measurement Study Findings  Comparing the response of the patients concerning their BP status to the 
current BP measurement obtained during this study, it was observed that one in three patients (30/105; 28.6%) 
who stated they had been diagnosed with HBP actually had HBP (systolic ≥ 140 mmHg and/or diastolic ≥ 
90mmHg), at the time of this study. Also: one in four participants (4/17; 23.5%) who stated that they were not 
sure of their BP status; one in five (51/275; 18.6%) who stated that they had not been diagnosed with HBP; one in 
six (8/46; 17.4%) patients who did not specify their BP status, showed HBP readings (Figure 4). Adding together 
those subjects with HBP, measured in this study, who were not sure of the prior BP status and those who said they 
had been given the all-clear at an earlier examination but excluding those subjects who had HBP but did not 
specify their initial BP status, there were 55 (out of 443) subjects whose BP readings were high (even on second 
BP measurement) but who were unaware of their BP status. That translates to one in 8 subjects (12.4%). With 
regard to the group of subjects who had previously been diagnosed with HBP (n = 105), thirty also had HBP in 
this study, some of whom (73.3%) were on medication (33.3% were on more than one medication). In contrast, of 
the other 75 subjects, 44% were on medication while only 6.7% were on more than one medication. These 
numbers suggest that the hypertension in the group of 30 subjects was more difficult to bring under control and a 
case may be made for placing hypertensive patients on multiple drug therapy in a higher risk category, whose BP 
should be monitored as frequently as possible. This is consistent with the recommendation made by Daubs[42] that 
optometrists could detect one undiagnosed hypertensive patient for every 14 adults tested by measurement of BP 
routinely. With the reported global increase in the prevalence of hypertension[52-55], and in line with previous 
reports on poor management of hypertension[56], it is not surprising that we found one undiagnosed hypertensive 
patient for every 8 adults tested. Although children were excluded in this study, screening them for HBP in eye 
clinics was shown to be beneficial in early detection of HBP [8, 56-58].  
The findings from this study support the potential role of the optometrist to contribute effectively to identification 
of the hypertensive patient. One advantage that may be specific to Saudi Arabia is that most optometry practices 
in the Kingdom place no charge for an eye examination. This makes them more accessible and adds to the 
advantage of being more geographically dispersed than hospitals, clinics, or GPs practices. This new expanded 
role for the Optometrist indeed would significantly impact the diagnosis of hypertension, if we also consider the 
people on single or multiple drug therapy whose BPs are still not under control and who might also be detected by 
such screening measures, the Optometrist could even help with the management of hypertensive disease.   
As a common draw back in survey studies, we could not expand the questions beyond the ones already asked. 
This was done to ensure high compliance. For example, we could have inquired about low blood pressure, asked 
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participants to specify which anti-hypertensive medications they were taking as well as dosage and duration of 
treatment. Even with the current length of the survey, many participants found it difficult to respond to majority of 
the questions asked. Another drawback of this study was the lack of follow up. Repeat measurements on another 
day would have been important especially for those patients with initial high readings, but for the purpose of the 
study we preferred to refer such patients to GPs for proper recommendations and advice. We could not confirm 
how many of the referred participants actually were diagnosed with hypertension after visiting their GPs, or how 
many participants actually heeded our referral advice. The responses from the survey were also self-reported. 
Future studies should follow up these patients and also assess the burden such referrals would place on the work 
load of the GPs.  
In conclusion, there is an increased awareness of hypertension in Saudi Arabia, but with a general poor attitude 
towards their cardiovascular health. Patients also do not think their BP status is related to their ability to see well. 
In-office BP measurement in optometry practice was able to detect one in 8 subjects (12.4%) with HBP who were 
previously unaware. Of the ‘aware’, BP was not properly controlled even as 28.6% of the patients still showed 
HBP readings despite that majority of them (73%) were on medications. Also, only 25% of the previously aware 
hypertensive patients owned a BP monitor. In general, almost all patients appreciated the routine measurement of 
BP in optometry practices and stated that it save time they would have spent visiting a hospital for such simple 
routine checks. These findings re-iterate the potential expanding role the optometrist could play in early detection 
and effective management of the hypertension as well as the need to further training. 
Recommendations  Firstly, the optometry institutions and the respective optometry associations (especially those 
in Saudi Arabia) should incorporate courses on hypertension, detection, management and treatment in their 
curriculum and continuous education segments. Secondly, the optometrists and the optometry associations should 
be more involved in public education and enlightenment campaign highlighting the importance of proper BP 
control to vision. Thirdly, optometrists should incorporate routine BP assessment in all adult patients using a 
clinically validated monitor in addition to other investigative tools already in place, especially in the absence of 
any law prohibiting them from doing so.  
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